Related Experiment Video
Updated: Dec 20, 2025
08:49
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
1.2K
Long-Term Renal Function Between Left Ventricular Assist Device Therapy and Heart Transplantation
1Second Department of Medicine, University of Toyama, Toyama, Japan.
Transplantation Proceedings
|June 3, 2020
Summary
Left ventricular assist device (LVAD) therapy shows better 1-year kidney function than heart transplantation. Further research on immunosuppressants and long-term outcomes is needed for renal dysfunction patients.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Renal dysfunction is a significant concern in patients with advanced heart failure.
- Left ventricular assist devices (LVADs) and heart transplantation (HTx) are established treatment options.
- Comparative renal outcomes between LVAD and HTx require further elucidation.
Purpose of the Study:
- To compare 1-year renal function in patients undergoing LVAD implantation versus HTx.
- To inform clinical decision-making for patients with renal dysfunction and end-stage heart failure.
Main Methods:
- Retrospective analysis of patient data comparing LVAD and HTx groups.
- Assessment of renal function markers at 12 months post-intervention.
Main Results:
- Patients with LVAD demonstrated superior renal function at 1 year compared to HTx recipients.
- This suggests potential renal benefits of LVAD therapy.
Conclusions:
- LVAD therapy may offer better short-term renal protection compared to HTx.
- Long-term renal outcomes and the impact of immunosuppression warrant further investigation.
Related Concept Videos
01:28Kidney Transplant I: Introduction
234
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
234
01:29Cardiomyopathy V: Interprofessional Care
214
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
01:22Heart Failure VI: Adjunct Therapies
171
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
171